Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC251001 - Phase II Randomized Double-Blinded Pilot Study of THC vs. THC/CBD (1:1) vs. Placebo for Insomnia in Patients With Cancer

NCT07565974 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07565974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07565974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC251001 - Phase II Randomized Double-Blinded Pilot Study of THC vs. THC/CBD (1:1) vs. Placebo for Insomnia in Patients With Cancer
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 1, 2027
Enrollment
69 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, malignant solid neoplasm